Pharmacological modulation of gut mucosal and large vessel blood flow

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 6, 2007, Pages 693-702

  Kamm, M A ^a,b   Jordan, C C ^a,b   Leaker, B R ^b   Nicholson, F B ^a   Murray, C D R ^a   Taylor, S ^a   Marshall, M ^a   Gibbs, A ^a   Carter, E G ^c   Emmanuel, A V ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b Yarra Medica Ltd   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; LOPERAMIDE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED HEADACHE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFERIOR MESENTERIC ARTERY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA BLOOD FLOW; SUPERIOR MESENTERIC ARTERY;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; COLON, TRANSVERSE; CONSTIPATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINAL MUCOSA; IPRATROPIUM; LASER-DOPPLER FLOWMETRY; LOPERAMIDE; MESENTERIC ARTERY, INFERIOR; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; RECTUM; REGIONAL BLOOD FLOW; SPLANCHNIC CIRCULATION;

EID: 33847083868     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03256.x     Document Type: Article

References (34)

1. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 450-7.
2. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93: 727-33.
3. Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
4. Murray CD, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004; 127: 1695-703.
5. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000; 9209: 1035-40.
6. Bradette M, Moennikes H, Carter F, Krause G, Caras S, Steinborn C. Cilansetron in irritable bowel syndrome with diarrhea predominance (IBS-D): efficacy and safety in a 6 month global study. Gastroenterology 2004; 126: A42.
7. Cole AJ, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM. Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 2004; 99: 486-91.
8. Miller DP, Alfredson T, Cook SF, Sands BE, Walker AM. Incidence of colonic ischemia, hospitalised complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride. Am J Gastroenterol 2003; 98: 1117-22.
9. Schoenfeld P. Review article: The safety profile of tegaserod. Aliment Pharmacol Ther 2004; 20 (Suppl. 7): 25-30.
10. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan JA. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol 1999; 94: 2430-4.
11. Carratu R, Parisi P, Agozzino A. Segmental ischemic colitis associated with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol 1993; 16: 31-4.
12. Deana DG, Dean PJ. Reversible ischemic colitis in young women. Association with oral contraceptive use. Am J Surg Pathol 1995; 19: 454-62.
13. Habu Y, Tahashi Y, Kiyota K, et al. Reevaluation of clinical features of ischemic colitis - analysis of 68 consecutive cases diagnosed by early colonoscopy. Scand J Gastroenterol 1996; 31: 881-6.
14. Matsumoto T, Iida M, Kimura Y, Nanbu T, Fujishima M. Clinical features in young adult patients with ischaemic colitis. J Gastroenterol Hepatol 1994; 9: 572-5.
15. Emmanuel AV, Kamm MA. Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000; 46: 212-7.
16. Scharff JR, Longo WE, Vartanian SM, Jacobs DL, Bahadursingh AN, Kamii DL. Ischemic colitis: spectrum of disease and outcome. Surgery 2003; 134: 624-9.
17. Emmanuel AV, Kamm MA. Laser Doppler measurement of rectal mucosal blood flow. Gut 1999; 45: 64-9.
18. van Oostayen JA, Wasser MN, van Hogezand RA, Griffioen G, de Roos A. Activity of Crohn disease assessed by measurement of superior mesenteric artery flow with Doppler US. Radiology 1994; 193: 551-4.
19. Efskind PS, Bernklev T, Vatn MH. A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. Scand J Gastroenterol 1996; 31: 463-8.
20. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the anti-diarrheal effect of loperamide. Gastroenterology 1984; 86: 1475-80.
21. Ruppin H. Review: Loperamide - a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther 1987; 1: 179-90.
22. Awouters F, Megens A, Verlinden M, Schuurkes J, Niemegeers C, Janssen PA. Loperamide. Survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sci 1993; 38: 977-95.
23. Saunders BP, Bell GD, Williams CB, Bladen JS, Anderson AP. First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut 1995; 36: 913-7.
24. Eidt JF, Harward T, Cook JM, Kahn MB, Troillett R. Current status of duplex Doppler ultrasound in the examination of the abdominal vasculature. Am J Surg 1990; 160: 604-9.
25. Blebea J, Volteas N, Neumyer M, et al. Contrast enhanced duplex ultrasound imaging of the mesenteric arteries. Ann Vasc Surg 2002; 16: 77-83.
26. Reed DE, Vanner SJ. Long vasodilator reflexes projecting through the myenteric plexus in guinea-pig ileum. J Physiol 2003; 553: 911-24.
27. Emmanuel AV, Kamm MA. Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut 2001; 49: 214-9.
28. Krohg-Sorensen K, Line PD, Kvernebo K. The significance of probe design in evaluation of colonic perfusion with laser Doppler flowmetry. Scand J Gastroenterol 1993; 28: 381-6.
29. Kvietys PR, Shephard AP, Granger DN. Laser Doppler, H2 clearance, and microsphere estimate of mucosal blood flow. Am J Physiol 1988; 88: 951.
30. Shepherd AP, Riedel GL. Continuous measurement of intestinal mucosal blood flow by laser Doppler velocimetry. Am J Physiol 1982; 242: G668-72.
31. Kolkman JJ, Otte JA, Groeneveld ABJ. Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology, and clinical applications. Br J Anaesth 2000; 84: 74-86.
32. Knichwitz G, Rotker J, Mollhoff T, Richter KD, Brussel T. Continuous intramucosal PCO2 measurement allows the early detection of intestinal malperfusion. Crit Care Med 1998; 26: 1550-7.
33. Dubin A, Estenssoro E, Murias G, et al. Effects of hemorrhage on gastrointestinal oxygenation. Intensive Care Med 2001; 27: 1931-6.
34. Hiltebrand LB, Krejci V, tenHoevel ME, Banic A, Sigurdsson GH. Redistribution of microcirculatory blood flow within the intestinal wall during sepsis and general anesthesia. Anesthesiology 2003; 98: 658-69.